Sildenafil in severe peripheral ischemia induced by terlipressin. A case report
暂无分享，去创建一个
[1] P. B. Berez. The Successful Use of Phosphodiesterase Type 5 Inhibitors to Treat the Syndrome of Cor Pulmonale and Prerenal Azotemia with Diuresis of Anasarca (CorPRADA) , 2010, Southern medical journal.
[2] A. Shindel. 2009 update on phosphodiesterase type 5 inhibitor therapy part 1: Recent studies on routine dosing for penile rehabilitation, lower urinary tract symptoms, and other indications (CME). , 2009, The journal of sexual medicine.
[3] E. Swenson,et al. Medication and dosage considerations in the prophylaxis and treatment of high-altitude illness. , 2008, Chest.
[4] Rashmi R Sharma. Novel phosphodiesterase-5 inhibitors: current indications and future directions. , 2007, Indian journal of medical sciences.
[5] M. Böhm,et al. Sildenafil in the Treatment of Raynaud’s Phenomenon Resistant to Vasodilatory Therapy , 2005, Circulation.
[6] C. Lau,et al. Severe digital ischaemia treated with phosphodiesterase inhibitors , 2004, Annals of the rheumatic diseases.
[7] R. Jalan,et al. Terlipressin-induced vasoconstriction reversed with N-acetylcysteine: a case for combined use in hepatorenal syndrome? , 2002, Gastroenterology.
[8] R. Moreau,et al. Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study. , 2002, Gastroenterology.